Inhibiting MAGL, which breaks down the brain's main endocannabinoid 2-AG, protected rat brain tissue from mitochondrial dysfunction and oxidative damage through both CB1 and CB2 receptors.
Neuroscience researchers, endocannabinoid drug developers.
Endocannabinoid-boosting enzyme inhibitor protected brain cells through multiple pathways
What the researchers found
JZL184 attenuated 3-NP-induced mitochondrial dysfunction and lipid peroxidation. CB2 primarily mediated mitochondrial protection, CB1 mediated anti-oxidative protection in synaptosomes. In cortical slices, protection was receptor-independent.
Why it matters
This approach boosts the brain's own endocannabinoids rather than adding external cannabinoids, potentially offering neuroprotection without psychoactive effects.
The numbers in context
CB2 mediated mitochondrial protection. CB1 mediated anti-oxidative protection. Both receptor-dependent and independent mechanisms found.
How the study worked
In vitro study using rat brain synaptosomes and cortical slices. Tested MAGL inhibitor JZL184 against 3-NP toxicity with CB1/CB2 antagonists.
What this study cannot tell us
In vitro study. Results differed between tissue preparations. Single toxin model.
How to read the evidence
In vitro study with appropriate controls but limited translational applicability.
When this study was published
Published 2023.
The bigger picture
Boosting endocannabinoid tone by blocking degradation enzymes is a promising neuroprotective strategy.
Questions still open
- Would MAGL inhibition protect in whole-animal models?
- Can the CB1/CB2 distinction inform non-psychoactive drug development?
Common questions
Can boosting the body's own cannabinoids protect the brain?
How does this differ from using cannabis?
Read the original research
Monoacylglycerol Lipase Inhibition Prevents Short-Term Mitochondrial Dysfunction and Oxidative Damage in Rat Brain Synaptosomal/Mitochondrial Fractions and Cortical Slices: Role of Cannabinoid Receptors.
Neurotoxicity research, 41(6), 514-525
Citation
Paredes-Ruiz, Karen Jaqueline; Chavira-Ramos, Karla; Galvan-Arzate, Sonia; Rangel-López, Edgar; Karasu, Çimen; Túnez, Isaac; Skalny, Anatoly V; Ke, Tao; Aschner, Michael; Orozco-Morales, Mario; Colín-González, Ana Laura; Santamaría, Abel. (2023). Monoacylglycerol Lipase Inhibition Prevents Short-Term Mitochondrial Dysfunction and Oxidative Damage in Rat Brain Synaptosomal/Mitochondrial Fractions and Cortical Slices: Role of Cannabinoid Receptors.. Neurotoxicity research, 41(6), 514-525. https://doi.org/10.1007/s12640-023-00661-4
Explore the wider topic
- How THC Affects Your Amygdala: The Brain's Threat Detector and Cannabis
- The Anandamide Connection: Your Body's Natural Bliss Molecule
- How Long for Cannabinoid Receptors to Return to Normal
- Cannabis and the Developing Brain: What Every Teenager (and Parent) Should Know
- Why Can't I Enjoy Anything Without Weed? The Science Behind It
- Dopamine Recovery After Quitting Weed: What the Science Says
- The Endocannabinoid System Explained Simply: What It Does and Why It Matters
- Your Endocannabinoid System Explained: Why Withdrawal Happens
- Your Nervous System After Quitting Weed: Fight or Flight
- Using Weed Under 18: What It Does to Your Developing Brain
- What THC Does to Your Brain: Why Withdrawal Happens
- THC and Your Prefrontal Cortex: What Cannabis Does to Your Decision-Making Brain
- Weed, Cortisol, and Stress: What Cannabis Does to Your Stress Hormones
- Weed and Memory: What the Science Says About THC and Your Hippocampus
- Weed and Motivation: Is Amotivational Syndrome Real?
- Weed and Your Nervous System: What THC Actually Does to Your Brain and Body
- How Weed Rewires Your Reward System (And How to Reset It)